This trial will see if evolocumab, a cholesterol-lowering drug, can prevent major cardiovascular events in high-risk adults who have not had a heart attack or stroke. This is a Phase 3 trial recruiting patients with CAD, Atherosclerotic Cerebrovascular Disease, or Peripheral Arterial Disease.
00:00:11 What is the time commitment for this trial?
00:00:22 Who is eligible to enroll?
00:00:55 Where is the trial based?
Review the trial details and get in touch with a trial coordinator through Power here: [ Ссылка ]
#myocardialischemiaclinicaltrial #myocardial #coronaryheartdiseaseresearch #clinicaltrials
![](https://s2.save4k.ru/pic/saqDrfZfUb8/maxresdefault.jpg)